Bank of America’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $120K | Buy |
11,714
+8,198
| +233% | +$69K | ﹤0.01% | 5494 |
|
|
2025
Q4 | $22.1K | Buy |
3,516
+3,509
| +50,129% | +$19.2K | ﹤0.01% | 6032 |
|
|
2025
Q3 | $21 | Sell |
7
-96
| -93% | -$248 | ﹤0.01% | 8157 |
|
|
2025
Q2 | $195 | Buy |
103
+10
| +11% | +$16 | ﹤0.01% | 7845 |
|
|
2025
Q1 | $136 | Sell |
93
-633,939
| -100% | -$1.26M | ﹤0.01% | 7769 |
|
|
2024
Q4 | $1.17M | Sell |
634,032
-15
| -0% | -$34 | ﹤0.01% | 4891 |
|
|
2024
Q3 | $1.5M | Buy |
634,047
+14
| +0% | +$36 | ﹤0.01% | 4770 |
|
|
2024
Q2 | $1.74M | Sell |
634,033
-2,605
| -0.4% | -$7.44K | ﹤0.01% | 4537 |
|
|
2024
Q1 | $2.66M | Buy |
636,638
+2,187
| +0.3% | +$7.92K | ﹤0.01% | 4217 |
|
|
2023
Q4 | $2.06M | Buy |
634,451
+7
| +0% | +$17 | ﹤0.01% | 4379 |
|
|
2023
Q3 | $1.9M | Hold |
634,444
| – | – | ﹤0.01% | 4293 |
|
|
2023
Q2 | $723K | Hold |
634,444
| – | – | ﹤0.01% | 5001 |
|
|
2023
Q1 | $1.06M | Hold |
634,444
| – | – | ﹤0.01% | 4855 |
|
|
2022
Q4 | $787K | Buy |
634,444
+500
| +0.1% | +$1.3K | ﹤0.01% | 5044 |
|
|
2022
Q3 | $2.67M | Sell |
633,944
-586
| -0.1% | -$2.36K | ﹤0.01% | 4022 |
|
|
2022
Q2 | $2.47M | Buy |
634,530
+237
| +0% | +$1.03K | ﹤0.01% | 4120 |
|
|
2022
Q1 | $3.1M | Buy |
634,293
+349
| +0.1% | +$1.79K | ﹤0.01% | 4142 |
|
|
2021
Q4 | $3.47M | Hold |
633,944
| – | – | ﹤0.01% | 4015 |
|
|
2021
Q3 | $2.29M | Sell |
633,944
-153
| -0% | -$583 | ﹤0.01% | 4313 |
|
|
2021
Q2 | $2.52M | Buy |
634,097
+153
| +0% | +$644 | ﹤0.01% | 4133 |
|
|
2021
Q1 | $3.03M | Hold |
633,944
| – | – | ﹤0.01% | 3882 |
|
|
2020
Q4 | $1.89M | Hold |
633,944
| – | – | ﹤0.01% | 3989 |
|
|
2020
Q3 | $2.02M | Hold |
633,944
| – | – | ﹤0.01% | 3672 |
|
|
2020
Q2 | $2.48M | Buy |
633,944
+630,879
| +20,583% | +$2.19M | ﹤0.01% | 3438 |
|
|
2020
Q1 | $10K | Buy |
3,065
+3,055
| +30,550% | +$10.5K | ﹤0.01% | 6355 |
|
|
2019
Q4 | $0 | Sell |
10
-1,025
| -99% | -$4.13K | ﹤0.01% | 7057 |
|
|
2019
Q3 | $4K | Buy |
1,035
+1,007
| +3,596% | +$3.96K | ﹤0.01% | 6878 |
|
|
2019
Q2 | $0 | Sell |
28
-1
| -3% | -$4 | ﹤0.01% | 7163 |
|
|
2019
Q1 | $0 | Buy |
+29
| New | +$110 | ﹤0.01% | 7084 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7249 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7068 |
|
|
2018
Q1 | – | Sell |
-8
| Closed | – | – | 7084 |
|
|
2017
Q4 | $0 | Buy |
+8
| New | +$118 | ﹤0.01% | 7013 |
|
|
2017
Q1 | – | Sell |
-5
| Closed | – | – | 6952 |
|
|
2016
Q4 | $0 | Buy |
+5
| New | +$622 | ﹤0.01% | 7013 |
|
|
2016
Q3 | – | Sell |
-1
| Closed | – | – | 7087 |
|
|
2016
Q2 | $0 | Buy |
+1
| New | +$345 | ﹤0.01% | 7106 |
|
Other funds holding ARMP
MAM
VCM
6CM
DIG
VFT
Bank of America's ARMP Position: Q1 2026 in Review
Bank of America increased its Armata Pharmaceuticals (ARMP) stake by 233% in Q1 2026, buying an estimated $69K and bringing the position to 11,714 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #5494.
Bank of America first reported a position in ARMP in Q2 2016 and has held it in 32 quarters since. The position peaked at $3.47M in Q4 2021. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.
- Bank of America held 11,714 shares of Armata Pharmaceuticals worth $120K as of Q1 2026.
- Bank of America bought 8,198 Armata Pharmaceuticals shares in Q1 2026, an estimated $69K.
- Armata Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5494 holding.
- Bank of America first reported a position in Armata Pharmaceuticals in Q2 2016 and has held it in 32 quarters since.
- Bank of America's Armata Pharmaceuticals position peaked at $3.47M in Q4 2021.
- 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.